Receptor mediated tumor targeting: an emerging approach for cancer therapy

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Receptor-mediated tumor targeting is a key strategy in cancer drug delivery.
• Targeting specific receptors on cancer cells allows for selective drug delivery.
• Nanocarrier systems conjugated with ligands offer improved drug pharmacokinetics and reduced systemic toxicity.

Purpose of the Study:

• To review the application of receptor-mediated targeting for anticancer drugs delivered via nanocarriers.
• To summarize current perspectives and challenges in nanocarrier-aided cancer drug delivery and targeting.

Main Methods:

• Literature review of receptor-mediated targeting strategies in cancer therapy.
• Analysis of nanocarrier systems used for drug delivery and targeting.
• Discussion of recent advancements and future challenges in the field.

Main Results:

• Receptor-mediated targeting enhances drug delivery to cancerous tissues.
• Nanocarriers improve drug protection and pharmacokinetics, minimizing off-target toxicity.
• Ligand conjugation to nanocarriers enables precise cellular or intracellular targeting.

Conclusions:

• Receptor-mediated targeting with nanocarriers shows significant promise for improving cancer treatment efficacy.
• Overcoming challenges in nanocarrier design and targeting is crucial for clinical translation.
• This approach offers a pathway to more selective and less toxic cancer therapeutics.